Latest News for Gafisa Stock (OTC:GFASY)

Gafisa SA is a Brazilian company that is engaged in the real estate development of residential units on behalf of third parties. It provides civil construction and civil engineering services, develops and implements marketing strategies related to its own and third-party real estate ventures, and invests in other companies that share similar objectives. The company operates in Sao Paulo and its metropolitan area.

Gafisa SA

Earnings

News

Suzano Q1 Net Revenue Decline 16% Y/Y To R$9.459B; Net Income Falls 96% Y/Y

Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) reported quarterly losses of $(0.26) per share. This is a 38.1 percent increase over losses of $(0.42) per share from the same period last year.

SNTI

Senti Biosciences Q1 EPS $(0.26) Up From $(0.42) YoY

Telesis Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) reported quarterly losses of $(5.52) per share which missed the analyst consensus estimate of $(0.23) by 2300 percent. The company reported quarterly sales of $3.440 million which missed the analyst consensus estimate of $6.900 million by 50.14 percent. This is a 45.54 percent decrease over sales of $6.316 million the same period last year.

Earnings Misses

TBIO

Telesis Bio Q1 2024 Adj EPS $(5.52) Misses $(0.23) Estimate, Sales $3.440M Miss $6.900M Estimate

Guidance

NGVC

Natural Grocers By Vitamin Cottage Sees FY24 EPS $1.08-$1.18

Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.11) by 27.27 percent. This is a 26.32 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $3.052 million which missed the analyst consensus estimate of $3.245 million by 5.95 percent. This is a 38.66 percent increase over sales of $2.201 million the same period last year.

RGTI

Rigetti Computing Q1 2024 GAAP EPS $(0.14) Misses $(0.11) Estimate, Sales $3.052M Miss $3.245M Estimate

Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) reported quarterly earnings of $0.20 per share. This is a 64.29 percent decrease over earnings of $0.56 per share from the same period last year. The company reported $14.10 million in sales this quarter. This is a 6.00 percent increase over sales of $13.30 million the same period last year.

CPHC

Canterbury Park Holding Q1 EPS $0.20 Down From $0.56 YoY, Sales $14.10M Up From $13.30M YoY

4D Molecular Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.78) by 15.38 percent.

Earnings Beats

FDMT

4D Molecular Therapeutics Q1 2024 GAAP EPS $(0.66) Beats $(0.78) Estimate

Lightbridge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTBR#NASDAQ">LTBR</a>) reported quarterly losses of $(0.21) per share. This is a 23.53 percent decrease over losses of $(0.17) per share from the same period last year.

LTBR

Lightbridge Q1 EPS $(0.21) Down From $(0.17) YoY

ADMA

ADMA Biologics Sees FY25 Revenue More Than $410M Vs $389.875M Est.

ADMA Biologics Sees FY24 Revenue More Than $355M Vs $333.875M Est.

The head of the Federal Deposit Insurance Corporation (FDIC) is set <a href="https://www.benzinga.com/topic/congress">to address Congress </a>next week amid allegations of sexism, abuse, and racism within the workplace.
What Happened: Martin Gruenberg, who has been at the <a href="https://www.benzinga.com/topic/fdic">helm of the FDIC</a> since January 2023, first joined the FDIC board in 2005 and also served as its chairman from November 2012 to mid-2018.
A third-party investigation has accused the FDIC of fostering a workplace that included sexual harassment and misconduct.
Gruenberg will face hearings from the House of Representatives Financial Services Committee on Wednesday, May 15 and the Senate Banking Committee on Thursday, May 16.
The FDIC chair faces bipartisan pressure to resign from the top position, but has also found support from some key figures in Congress.
"The Cleary report places the focus for ‘tone at the top' solely on the Democratic chair under whose leadership the agency received the most favorable ratings from its employees, while it completely ignores the activities of the two previous Republican chairs," Rep. Maxine Waters (D-Calif.) said Thursday, as <a href="https://thehill.com/business/4653986-maxine-waters-backs-fdic-chair-after-sexual-harassment-report/">shared </a>by The Hill.
Waters said the report was "troubling" and that changes are needed in FDIC policies and programs. The congresswoman serves on the House Financial Services Committee.
Press Secretary Karine Jean-Pierre was asked about the report earlier in the week. Jean-Pierre didn't answer a question on if Biden still had confidence in Gruenberg leading the FDIC but told reporters that the FDIC chairman had "apologized and has committed to the recommendations" in the Cleary report, as <a href="https://www.wsj.com/finance/regulation/fdic-chairmans-future-hinges-on-high-stakes-hearings-70f35763">shared </a>by The Wall Street Journal.
Senator Elizabeth Warren (D-Mass.) showed support for Gruenberg earlier in the week, saying that the FDIC chairman apologized already. Warren said she backed "his work to implement the action plan to improve the FDIC's culture."
Related Link: <a href="https://www.benzinga.com/news/22/05/27056147/5-things-you-might-not-know-about-joe-bidens-new-press-secretary-karine-jean-pierre">5 Things You Might Not Know About Karine Jean-Pierre, Joe Biden&#8217;s Press Secretary</a>
Why It's Important: Gruenberg has been a member of the FDIC for over 20 years, and been the chairman or acting chairman on multiple occasions.
The report points to problems at the FDIC for years, which may have been a period of time when he was not the chairman.
Experts say Gruenberg might have to walk a fine line of admitting to problems and apologizing, while also pointing to how the FDIC will move past the issues when addressing Congress.
Released on Tuesday, the Cleary report said the FDIC needs "cultural and structural changes." The investigation was prompted by stories published by The Wall Street Journal pointing to misconduct at the agency.
According to <a href="https://www.politico.com/news/2024/05/07/fdic-workplace-misconduct-00156570">Politico</a>, the Cleary report also points to Gruenberg "losing his temper and interacting with staff in a demeaning and inappropriate manner." The report questions if Gruenberg is the right person to lead the agency through policy changes.
The report also found that responses to allegations of misconduct were "insufficient and ineffective."
"While we do not find Chairman Gruenberg's conduct to be a root cause of the sexual harassment and discrimination in the agency or the long-standing workplace culture issues identified in our review, we do recognize that, as a number of FIDC employees put it in talking about Chairman Gruenberg, culture ‘starts at the top,'" the report said.
Gruenberg has apologized and said he plans to stay in his current role.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38431860/maxine-waters-says-stablecoin-bill-in-the-short-run-coming">Maxine Waters Says &#8216;Stablecoin Bill In The Short Run&#8217; Coming</a>
Photo: Shutterstock

Government

Regulations

Politics

General

Maxine Waters, Elizabeth Warren Back FDIC Chairman With Agency Under Fire For Toxic Workplace

Coherus BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.24) by 33.33 percent. This is a 57.33 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $77.063 million which missed the analyst consensus estimate of $80.248 million by 3.97 percent. This is a 137.58 percent increase over sales of $32.436 million the same period last year.

CHRS

Coherus BioSciences Q1 2024 Adj EPS $(0.32) Misses $(0.24) Estimate, Sales $77.063M Miss $80.248M Estimate

TELA Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELA#NASDAQ">TELA</a>) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.50) by 8 percent. This is a 14.29 percent increase over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $16.603 million which beat the analyst consensus estimate of $16.319 million by 1.74 percent. This is a 39.42 percent increase over sales of $11.909 million the same period last year.

TELA

TELA Bio Q1 2024 Adj EPS $(0.54) Misses $(0.50) Estimate, Sales $16.603M Beat $16.319M Estimate

Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.79) by 30.38 percent. This is a 90.88 percent increase over losses of $(6.03) per share from the same period last year. The company reported quarterly sales of $25.944 million which beat the analyst consensus estimate of $25.450 million by 1.94 percent. This is a 50.57 percent increase over sales of $17.230 million the same period last year.

OUST

Ouster Q1 2024 GAAP EPS $(0.55) Beats $(0.79) Estimate, Sales $25.944M Beat $25.450M Estimate

Tyra Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TYRA#NASDAQ">TYRA</a>) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.46) by 23.91 percent.

TYRA

Tyra Biosciences Q1 2024 Adj EPS $(0.35) Beats $(0.46) Estimate

<a href="https://www.globenewswire.com/Tracker?data=ZuTFc-zVOu1e0Nl1Bl3W_FvNCjuaBHEuo0eglQiy-FP2VQMWLUtNGdj188N_ck6x7yK9HwyAUbV6mVz1wVApVlCWy-AA_H-9crmTE_XB_LM=">CompoSecure, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPO#NASDAQ">CMPO</a>), a leader in metal payment cards, security, and authentication solutions, today announced its partnership with Robinhood Markets, Inc., and Fiserv that led to the creation of the premier Robinhood Gold Card, one of the most innovative payment card programs available today. &nbsp;
"In combination with our ambitious card program, having a unique form factor was important to us to define what we consider an entirely new product category within the payment card market," said Deepak Rao, General Manager of Robinhood Money. "Partnering with CompoSecure helped us realize our vision of delivering a card that is beautiful and accessible to all with some of the best rewards in the industry."

CMPO

HOOD

CompoSecure Announces Partnership With Robinhood Markets, And Fiserv That Led To The Creation Of The Premier Robinhood Gold Card

American Coastal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.25 by 100 percent. This is a 28.57 percent decrease over earnings of $0.70 per share from the same period last year. The company reported quarterly sales of $68.730 million which beat the analyst consensus estimate of $62.412 million by 10.12 percent. This is a 21.29 percent decrease over sales of $87.324 million the same period last year.